Managing Director Succession Planning: A Practical Guide for UK Businesses

Managing Director Succession Planning: A Practical Guide for UK Businesses

Most Managing Director succession fails not because the wrong person is chosen, but because the process starts too late. By the time a board is actively thinking about MD succession, the window for an orderly, low-disruption transition has frequently already closed. The incumbent is leaving in three months, the business has no internal candidate who is ready, and the board is facing a search under conditions of genuine urgency that will compromise both the timeline and the quality of the outcome.

This guide covers how to build a practical succession framework for the MD seat, when to start the process, how to assess internal candidates honestly, when to run an external Managing Director search alongside or instead of internal development, and how to structure the transition once a successor is identified.

For the practical hiring process once the succession decision has been made, see our How to Hire a Managing Director guide. For the attributes to assess in MD candidates, see our What Makes a Great Managing Director guide.

Why MD succession fails

The Chartered Management Institute’s research on succession planning in UK businesses consistently finds that fewer than a third of companies have a formal succession plan for their most senior leadership role. The gap between the aspiration (“we have internal talent”) and the reality (that talent has not been developed to the point of readiness) is the consistent pattern.

Three specific failure modes recur.

The assumption of internal readiness. The board assumes the COO or CFO is ready to step up to the MD role when the time comes. The assumption is rarely tested until the succession event occurs — at which point the gap between the internal candidate’s actual readiness and the role’s requirements becomes visible. The internal candidate is appointed anyway, typically because the alternative is acknowledging that the board has failed to develop internal succession, and the appointment underperforms.

The deferred conversation. MD succession is not discussed while the incumbent is performing well because raising succession feels like a vote of no confidence in the current MD. This is the most common single cause of compressed succession timelines. The conversation that would have been straightforward eighteen months before the transition becomes difficult because the transition is now imminent and the incumbent’s departure is sensitive.

The departure without notice. MD departures from illness, relocation, attractive external opportunity or irreconcilable board disagreement are more common than planned retirements in the UK SME and mid-market. Businesses that have not built succession frameworks before an unplanned departure are exposed to the most adverse version of the MD succession problem: needing to appoint quickly, from a position where internal readiness has not been assessed, with the business in a state of uncertainty that affects staff, customers and suppliers simultaneously.

The succession planning timeline

A working rule: MD succession planning should begin three years before the anticipated transition, not three months.

Three years before an anticipated MD transition allows the following sequence: an honest internal talent assessment in year one; a structured capability development programme for identified internal successors during year two; an external market scan during year three to calibrate internal candidates against the external market; and a twelve-to-eighteen month transition period in which the identified successor operates in an expanded role with increasing board exposure before formally stepping into the MD seat.

This timeline is rarely achieved in practice. Most boards begin the succession conversation eighteen months before the anticipated transition, which is functional but compressed. Anything under twelve months means the process is reactive rather than planned, and the board’s options are materially narrowed. Anything under six months is a crisis mode succession that will produce a suboptimal outcome regardless of how well the search is run.

The UK Government’s guidance on directors’ responsibilities makes clear that boards have an ongoing obligation to ensure proper management of the company. A board without a succession plan for the MD role is not meeting this obligation — though the obligation is rarely enforced except in regulated industries where the FCA’s Senior Managers Regime requires specific approval for SMF-designated roles.

The internal vs external decision

The default assumption in most owner-managed and PE-backed businesses is that MD succession should be internal — promotion of the COO, CFO or a senior operational director. This default is often correct, but it should be tested rather than assumed.

The case for internal succession

Internal succession is the right answer when: the business is in a stable-growth phase where continuity of relationships, customer trust and operating model is more valuable than the transformation capability an external candidate might bring; the identified internal candidate has already effectively operated at MD level during a gap, a maternity cover or a period of the MD’s absence; the cultural and ownership dynamic is idiosyncratic enough that an external MD would face a significant acculturation period that the business cannot afford; or the business has genuinely invested in developing the internal candidate over a two-to-three year period and the candidate’s readiness has been tested through stretch assignments.

The strongest internal succession cases have one characteristic in common: the board has been deliberate about it. The internal candidate has been given board exposure, P&L responsibility, external stakeholder relationships and the opportunity to demonstrate their readiness in conditions that approximate the MD role. Their promotion is the validation of an investment, not a hope that they will grow into it.

The case for an external search

An external Managing Director search is the right answer when: the commercial challenge that will define the next chapter of the business requires a capability step-change that no internal candidate has demonstrated and cannot be developed fast enough; the business is entering a new phase — PE investment, international expansion, sale preparation, digital transformation — where external experience of that specific transition is a primary requirement; the strongest internal candidates are themselves at risk of departure if they are not appointed, making the succession decision higher-stakes and less reversible; or the current MD’s departure is creating a leadership vacuum that the business cannot sustain while a twelve-to-eighteen month internal development programme runs.

The honest version of the internal vs external question requires a structured comparison: what does the best realistic internal candidate look like on a structured assessment, and how does that profile compare to what the external market can offer? That comparison requires running at least a light-touch external market scan in parallel with the internal assessment — not to replace the internal candidate, but to calibrate honestly whether the organisation is holding itself to the right standard. Boards that do not run this comparison frequently discover after the fact that the internal candidate they promoted was not actually competitive with the external market they chose not to explore.

Assessing internal succession candidates

Internal MD succession candidates should be assessed against the same framework as external candidates — not a softer one because of their familiarity, their loyalty or the awkwardness of formal assessment with someone who has been a colleague. The consequence of under-assessing an internal candidate is an appointment that fails for the same reasons any under-assessed external appointment fails: the board was not explicit about what they needed, so they could not test whether the candidate could deliver it.

Three assessment approaches work well for internal succession candidates:

Stretch assignment with real accountability

Give the internal candidate genuine P&L accountability and board-level exposure for a defined period — six months minimum, twelve months ideally. Not “acting MD” in name while the incumbent remains substantively in role, deciding the commercial calls and representing the business to key stakeholders. Real accountability for specific commercial outcomes, with the board watching the candidate’s performance in those outcomes rather than just the MD’s assessment of it.

The quality of that performance, and the board’s direct observation of the candidate in board interactions, stakeholder meetings and commercial pressure situations, is the most reliable data point for succession readiness. It is much more reliable than the incumbent MD’s assessment — which is typically coloured by the relationship, the MD’s pride in having developed the candidate, and the MD’s own departure anxiety.

External benchmarking

Run a structured assessment conversation with the internal candidate alongside two or three external reference-point conversations. Not a full external search, but enough external benchmarking to understand whether the internal candidate is genuinely strong in the external market or strong relative to an internal peer group that may not be a reliable comparator. The external benchmarking also provides the board with language for explaining the decision whichever way it goes: “we benchmarked internally and externally and [internal candidate] was the strongest candidate we saw” is a more credible communication than “we decided to promote internally.”

Reference-adjacent conversations

Speak to people who have worked with the internal candidate in peer or reporting roles, including in previous companies. The pattern of how someone has operated over time and across different business contexts — not just in their current environment, under the current MD’s leadership style — is what succession assessment is actually trying to evaluate. References from the current organisation are valuable but partial; they capture performance in one context under one type of leadership.

Structuring the transition

Once a successor is identified — internal or external — the transition structure matters as much as the selection decision.

Internal succession transitions

For internal successors, a twelve-month transition period is the minimum for a well-run handover. This should include three distinct phases: a three-month period of formal co-operation where the outgoing MD progressively transfers key customer relationships, bank and investor relationships, and institutional knowledge to the successor; a three-to-six month period where the successor is leading board interactions and representing the business externally, with the outgoing MD in a defined supporting role; and a clean-break date after which the outgoing MD has no active role in the business, with defined clarity for all stakeholders about the handover date and what changes.

The most common transition failure is the outgoing MD who remains informally involved beyond the clean-break date — attending management meetings without a formal mandate, taking calls from senior staff who have maintained the relationship, giving opinions on commercial decisions through informal channels. This undermines the successor’s authority with the team and creates a confusing governance situation where staff are uncertain who is actually running the business.

External MD appointment transitions

For external MD appointments, the transition challenge is different: the incoming MD needs access to institutional knowledge, customer relationships and cultural context that is not in any document and cannot be absorbed from a briefing pack. The board’s active involvement in relationship introductions during the first ninety days is a material determinant of how quickly the new MD becomes commercially effective.

See our Executive Onboarding Guide for a full treatment of how to structure the first ninety days of a new senior appointment.

The board’s role in MD succession

MD succession is a board responsibility, not an HR exercise. The board chair owns it. The CEO or outgoing MD informs it. The board decides it.

Four specific board roles in MD succession:

Owning the timeline. The board should set the succession planning trigger — whether that is a planned retirement date, a business milestone such as PE investment or planned sale, a performance review or a regulatory requirement — and hold the process to that trigger. Not delegating the initiation of succession planning to the incumbent MD, who has an obvious interest in the timing.

Commissioning the internal assessment. The chair or a designated non-executive director, rather than the CEO or incumbent MD, should lead the assessment of internal candidates. The incumbent MD has a structural conflict in assessing their potential successors: they may prefer a weaker internal candidate who will not overshadow them, or a stronger one who will be seen as their legacy. Neither preference is a reliable guide to what the business needs.

Deciding the internal/external balance. Using an honest external benchmarking exercise rather than internal assumption or political preference. The board should be able to describe the evidence basis for the succession decision, not just the outcome.

Managing the announcement. MD succession announcements have material impacts on customer relationships, senior team retention and, in regulated businesses, regulatory notification requirements. The communication plan should be developed alongside the succession plan, with specific plans for key customer communications, team announcements, supplier communications and (where applicable) bank and investor notifications. The Companies House notification requirements for director changes should be addressed within the statutory timeframe.

Using a retained search firm for MD succession

A retained search firm adds most value in MD succession when: the board has decided to run an external search as the primary route or as a competitive benchmark alongside an internal candidate; the succession timeline is compressed and the speed of a well-resourced retained search is commercially necessary; or the board wants an external perspective on the internal vs external question before deciding.

Exec Capital runs Managing Director searches as retained mandates with a brief development process that includes the succession context — the transition structure, the board relationship dynamic, the outgoing MD’s involvement in the handover — as core components of the brief rather than afterthoughts. For succession situations where the internal/external balance is genuinely uncertain, we can run a structured market intelligence exercise — a light-touch external scan that provides benchmarking without committing to a full external search — to help the board make an informed decision.

Further reading

For the practical hiring process, see our How to Hire a Managing Director guide. For assessment frameworks, see our What Makes a Great Managing Director guide. For the retained search methodology, see our Executive Search Methodology guide. For onboarding the new MD, see our Executive Onboarding Guide.

External resources: the Chartered Management Institute’s succession planning research provides a useful UK benchmarking reference. The ICAEW’s board practice guidance on succession planning covers the governance dimensions at board level.